| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.deccanhealthcare.co.in / www.beyoungstore.com | |
| Market Cap | 58.88 Cr. | |
| Enterprise Value(EV) | 57.47 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.19 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 182.53 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 32.54 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 48.08 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 0.72 | Calculated using Price: 34.55 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.70 Cr. | 17,043,180 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc. | ||
| 1 Day |
|
+1.62% |
| 1 Week |
|
-0.72% |
| 1 Month |
|
-16.44% |
| 3 Month |
|
-28.76% |
| 6 Month |
|
+0.44% |
| 1 Year |
|
+27.73% |
| 2 Year |
|
+33.14% |
| 5 Year |
|
|
| 10 Year |
|
| 2 years | 2021-03 | 2022-03 | |
| Return on Equity (%) | 0.51 | 0.42 | |
| Return on Capital Employed (%) | 0.81 | 0.89 | |
| Return on Assets (%) | 0.42 | 0.35 |
| Particulars | 2 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | 77 | 77 | |
| Non Curr. Liab. | 3 | 3 | |
| Curr. Liab. | 13 | 10 | |
| Minority Int. | |||
| Equity & Liab. | 92 | 91 | |
| Non Curr. Assets | 26 | 23 | |
| Curr. Assets | 66 | 68 | |
| Misc. Exp. not W/O | |||
| Total Assets | 92 | 91 |
| Particulars | 2 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 34 | 33 | |
| Other Income | 0 | 0 | |
| Total Income | 34 | 33 | |
| Total Expenditure | -32 | -28 | |
| PBIDT | 2 | 6 | |
| Interest | 0 | 0 | |
| Depreciation | -1 | -1 | |
| Taxation | 0 | 0 | |
| Exceptional Items | -3 | ||
| PAT | 0 | 0 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 0 | 0 | |
| Adjusted EPS | 0 | 0 |
| Particulars | 2 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -1 | |
| Cash Fr. Inv. | 0 | 0 | |
| Cash Fr. Finan. | 0 | 0 | |
| Net Change | 0 | -1 | |
| Cash & Cash Eqvt | 3 | 3 |
|
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 we wish to inform you that the entire holding of DHCL is in dematerialized form and we have not received any dematerialization and re-materialization requests from any of the shareholders of our company during the quarter ended December 31 2022 hence the aforementioned regulation does not apply to our company. |
|
Wed, 07 Dec 2022
Appointment of Company Secretary and Compliance Officer This is to inform you that the Board of Directors of Deccan Healthcare Limited in their meeting held on 7th December 2022 has appointed Ms. Vaishali Gagnani as the Company Secretary Compliance Officer and Key Managerial Personnel of the Company w.e.f 07th December 2022 |
|
Wed, 07 Dec 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held Today 07Th December 2022 As per captioned subject and reference to our Intimation vide letter dated 25th November 2022 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Wednesday December 07 2022 has approved as per Attached Outcome |
| Tue, 31 Jan 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors